Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. - sprookjes - yvandenbroek - TriplyDB

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

http://www.wikidata.org/entity/Q34973731

about

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation.Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection.Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity.Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.Modulation of phosphorylation of tocopherol and phosphatidylinositol by hTAP1/SEC14L2-mediated lipid exchange.An overview of lymphatic vessels and their emerging role in cardiovascular disease Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis The Naïve Murine Cornea as a Model System to Identify Novel Endogenous Regulators of Lymphangiogenesis: TRAIL and rtPA.Lymphatics and lymphangiogenesis in the eye.Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway.Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation Progression of lumbar spinal stenosis is influenced by polymorphism of thrombospondin 2 gene in the Korean population Inflammation-associated lymphangiogenesis: a double-edged sword?Antiangiogenic and anticancer molecules in cartilage.Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?Inflammatory lymphangiogenesis: cellular mediators and functional implications.Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.Lymphangiogenic factors, mechanisms, and applications.Roles of exosomes in the normal and diseased eye.Alloimmunity and Tolerance in Corneal Transplantation.New insights into mononuclear phagocyte biology from the visual system.Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency.Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway.The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density.Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner.Lymphangiogenesis guidance by paracrine and pericellular factors.Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.α-Tocopheryl Phosphate Induces VEGF Expression via CD36/PI3Kγ in THP-1 Monocytes.CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: Implications for the safety of the therapy.

P2860

Q26823757-2A20BC4D-66F5-42A7-90A7-76ADACD3E916 Q30278005-935A0A8F-12A4-4CE0-8583-F31EF16547BB Q34277464-BA3EB9CE-A9EE-43C1-B720-232E57383224 Q34342168-F8E0CC54-7AE4-4D24-8207-A9E84304D3BB Q34594843-E5F68CC8-BD9A-4249-98DC-9C401BF024D2 Q34608976-C2DA76C1-C40E-494F-9FB5-B6AEFDAD1AB1 Q34881185-7D8168F3-64C7-454E-B985-0A5EBFA37EEF Q35006085-62597710-22E9-41AE-A80C-D4D6E764EEC6 Q35199264-F9282E98-8FDF-4A37-869A-D1AE44397F1C Q35366220-572DE2B0-6DCD-459A-BEB8-255ED78DA7BA Q35672575-299792AB-43E5-475D-97B6-C63D29CC530D Q35679807-7C3674FC-F929-4FD2-9EA3-0A0F9E31B434 Q35810928-4665E1B1-2FB6-4487-95DB-0E75969A7C85 Q35822076-EADC1EEC-811C-4A2F-AA94-FAAFF8B1AB5E Q35864976-7A65BD74-44AC-495E-9A69-F8DF6CC352C6 Q35907009-2A7DC9A9-5259-4EC0-953B-45FFA0FC632F Q35996002-EBDCD9A2-CAE6-41B5-856A-CC98550ACF66 Q36074078-FEC86F8C-6C6C-4A03-B5A6-F049D10E5751 Q36241623-2D67DEE6-232D-466D-BFAB-8901BD858B53 Q36808641-4D095C28-27D0-4F85-A324-709600E2EBD4 Q37093613-CC334169-F2EB-4AAD-A830-14167359B91B Q37500758-430B6FBF-D344-41C9-B17A-808547140AF2 Q37609665-0B833A64-488A-45B1-99C2-C14E472DDB9E Q38007565-5DA0C7CD-368F-4A35-98F0-EB2316DAFACF Q38123280-9D2D2277-A455-4586-947F-DF95F4168434 Q38180633-927C042C-4D44-4E01-B311-B76D8E15F822 Q38190108-C27739EC-8774-4354-B35C-3112E480BBA3 Q38192927-7CC0DB13-E79F-4BEE-8809-1D659D7F145D Q38688358-50B1F5C2-D067-47B5-A8DC-A704BB06AC09 Q38835393-013B051F-34F2-4C97-B24C-31F0D29B0FAB Q39202010-479B50A1-05F4-496C-B33C-5F1EA34C8938 Q41244028-F6ABD1AC-2950-49C2-95D0-CE6942FCE733 Q41636753-52768EA9-E26D-48EA-8241-1BB0F11A7A4B Q41720764-43B44922-1AB4-462F-B739-600E2EE072C4 Q47209508-15EBAB2C-CA95-40AD-AEB6-499EBF011A12 Q47744569-62D99D9F-A7F6-444E-86EC-6D2C4A8A787C Q47958441-00D55D2C-B8A2-4E20-B10D-7758954503F8 Q47994440-EB8D200C-6639-4320-A4A3-73BE7FE08DFB Q48088461-5A727C1E-93F7-49EE-9AFC-942FF056F2AD Q50615237-42922B4F-FBE9-4FE9-8AAA-4B43D2B6FC4E

P2860

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

http://www.wikidata.org/entity/Q34973731

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@ast

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@en

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@nl

type

label

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@ast

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@en

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@nl

prefLabel

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@ast

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@en

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@nl

P1433

Q34973731-20A3B070-CEB8-46C4-83AE-604AFDF641FB

P1476

Q34973731-06C8E5C9-6CD4-4AD1-A8C4-9110619115BA

P2093

Q34973731-22366B28-8817-4AA5-96D1-10C6C2133F7B

Q34973731-3F225E9D-02C3-4D66-BFB6-918DE5D28853

Q34973731-635DF23A-6426-41DF-B4A2-0AF9EF2592C3

Q34973731-696034C3-636D-4DB7-818C-49E95BC1B4F5

Q34973731-E1E9507A-2C00-4809-8316-80E157F14DF6

Q34973731-E975A7F5-AE4A-436E-816B-0D03273E3BEE

Q34973731-FB493037-6929-45E7-A3F6-8476150E7729

P2860

Q34973731-0285CA23-715F-4E95-86FB-17774AD745FF

Q34973731-06711B62-25AD-48AA-A5C3-E0803D60F640

Q34973731-15C35F07-E82B-4A8F-9ECC-DA40597FC53A

Q34973731-20A70783-C1BC-4CAA-80C0-FBE7555E57BC

Q34973731-2F206ACE-392B-447B-95BA-93BEE5A00A74

Q34973731-2F8302DB-30F1-4E56-9D4F-E2371847FEF9

Q34973731-36E810FC-EFCE-4BD1-9B5D-A7FC71EA3656

Q34973731-3CE63F9A-5F0F-44F4-B818-2846B9F3754A

Q34973731-47ABCA6B-BC3D-4381-992B-722FDA47A608

Q34973731-4AF25FA6-50D6-4AFE-B107-ECD77A06052D

P304

Q34973731-2AED291E-414B-4575-80C5-B8531EAF8E44

P31

Q34973731-E7D609A0-6EB4-4350-8CEE-9218C609EBC7

P356

Q34973731-2DF4ECDD-82A2-4518-A7B9-D128AF23B6EE

P407

Q34973731-5BD67E10-D477-41EB-8110-3295A8495AA5

P433

Q34973731-91E821F4-C552-477A-AB0A-2E36FD0490AC

P478

Q34973731-4D1FBFD2-F544-4AAB-89D4-1929BFB2194E

P50

Q34973731-93219DC8-36AC-4C6D-B5F4-ED7AA21779EA

P577

Q34973731-F8C6E170-3967-44F9-B3D7-C737A47097CA

P5875

Q34973731-96E7D880-45FD-48BC-A4DC-E84A0708CD1A

P698

Q34973731-842E1F97-5B5A-4DA7-AD3D-B789B7445F5B

P921

Q34973731-BB831F67-D105-4492-B300-726D36F0AFE4

Q34973731-BF590DDA-17C8-41A4-B140-A785D96B52AF

P932

Q34973731-0A188974-5F20-4ABF-8C6F-0C1CB7710AEF

P356

P1433

Journal of Experimental Medicine

P1476

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.

@en

P2093

Daniel Saban

http://www.w3.org/2001/XMLSchema#string

Felix Bock

http://www.w3.org/2001/XMLSchema#string

Jack Lawler

http://www.w3.org/2001/XMLSchema#string

Kazuichi Maruyama

http://www.w3.org/2001/XMLSchema#string

Reza Dana

http://www.w3.org/2001/XMLSchema#string

Sharmila Masli

http://www.w3.org/2001/XMLSchema#string

Zahra Sadrai

http://www.w3.org/2001/XMLSchema#string

P2860

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

Angiogenesis in cancer and other diseases

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin

Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism

Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36

Corneal avascularity is due to soluble VEGF receptor-1

Angiogenesis in cancer, vascular, rheumatoid and other disease

P304

1083-1092

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20092277

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P50

Claus Cursiefen

P577

2011-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51092777

http://www.w3.org/2001/XMLSchema#string

P698

21536744

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

3092349

http://www.w3.org/2001/XMLSchema#string